Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Generex Biotechnology Corporatio (GNBT)

Generex Biotechnology Corporatio (GNBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Global Protein Therapeutics Market is expected to grow from USD 56,236.13 Million in 2018 to USD 91,756.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%

, /PRNewswire/ --The Global Protein Therapeutics Market is expected to grow from in 2018 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%. Read the full report: The positioning...

AMGN : 229.21 (+1.01%)
BAX : 78.00 (+2.20%)
LLY : 148.45 (+3.01%)
GNBT : 0.2300 (+6.98%)
NVO : 67.81 (+0.89%)
Advanced Drug Delivery Systems Market to Witness Huge Growth by 2025 |3M, Allergan PLC, Theraject

- The exploration report comprised with market data derived from primary as well as secondary research techniques. The points covered in this study are primarily factors which are considered to be market...

BAX : 78.00 (+2.20%)
GNBT : 0.2300 (+6.98%)
IAIC : 1.0300 (-1.90%)
MYL : 15.85 (+1.96%)
VRX.TO : 30.80 (-3.33%)
Why the U.S. is "Flying in the Dark" Without Quicker Ability to Diagnose COVID-19

It seems that every hour of every day recently, on the internet, in print and on TV more about the Coronavirus situation continues to grow. There is so much new data on the subject every minute. But that...

IBIO : 1.4900 (-1.97%)
HWKE : 0.4250 (-3.41%)
NVAX : 126.25 (-2.25%)
GNBT : 0.2300 (+6.98%)
VXRT : 7.80 (+1.04%)
Advanced Drug Delivery Systems Market Growing Opportunity 2020 to 2026

AGN : 193.02 (+0.02%)
BAX : 78.00 (+2.20%)
GNBT : 0.2300 (+6.98%)
MYL : 15.85 (+1.96%)
VRX.TO : 30.80 (-3.33%)
PFE : 40.34 (+0.62%)
MMM : 172.46 (+0.37%)
Generex Biotechnology Discusses Coronavirus Solutions with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - February 6, 2020) - The Stock Day Podcast welcomed Generex Biotechnology (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end solutions...

GNBT : 0.2300 (+6.98%)
The Comprehensive Study on About Global Advanced Drug Delivery Systems Market 2020 by Growth Factors, Applications, Regional Analysis, Key Players like

BAX : 78.00 (+2.20%)
GNBT : 0.2300 (+6.98%)
MYL : 15.85 (+1.96%)
VRX.TO : 30.80 (-3.33%)
Generex Biotechnology Appoints Independent Directors Craig Eagle, MD and Thomas Leonard to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointments of Dr. Craig Eagle, MD and Mr. Thomas Leonard to the...

PFE : 40.34 (+0.62%)
GNBT : 0.2300 (+6.98%)
Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology...

GNBT : 0.2300 (+6.98%)
Generex Biotechnology Corporation Discusses Upcoming Revenue Increases and Growth with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - October 7, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end...

GNBT : 0.2300 (+6.98%)
Generex Engages Donohoe Advisory to Assist with Uplisting

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that Generex has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory")...

GNBT : 0.2300 (+6.98%)
The Stock Day Podcast Hosts Generex Biotechnology Corporation to Discuss Uplisting on the NASDAQ

Phoenix, Arizona--(Newsfile Corp. - July 1, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end...

GNBT : 0.2300 (+6.98%)
Generex Announces Update on 1:1 Dividend and NASDAQ Listing

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today provided guidance on the previously announced 1:1 GNBT stock dividend. After discussing...

GNBT : 0.2300 (+6.98%)
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

-- Launch of ExcellagenÃ’ for Wound Healing by subsidiary Olaregen Therapeutix

GNBT : 0.2300 (+6.98%)
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

MIRAMAR, Florida , April 29, 2019 /PRNewswire/ --

GNBT : 0.2300 (+6.98%)
MBRX : 0.8480 (+0.94%)
Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.

Inventor Dr. Lois Chandler, PhD Presents Excellagen(R) Clinical Trial Data Demonstrating Rapid Healing of Diabetic Neuropathic Foot Ulcers

GNBT : 0.2300 (+6.98%)
Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th

via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced an online presentation scheduled next week for Wednesday, April 17, where management will...

KALY : 0.0011 (-8.33%)
PURA : 0.0158 (+6.76%)
GNBT : 0.2300 (+6.98%)
Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors

Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing

GNBT : 0.2300 (+6.98%)
Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing

via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second quarter, filed on March 25, 2019, and its subsequent non-reliance...

GNBT : 0.2300 (+6.98%)
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million

Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex' Obligations

GNBT : 0.2300 (+6.98%)
USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY

via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) ("USMJ") and Puration Inc. (USOTC: PURA) ("PURA") today published an update on the progress the two companies are making toward their...

USMJ : 0.0003 (+50.00%)
PURA : 0.0158 (+6.76%)
PJET : 0.0008 (+14.29%)
NOUV : 0.0002 (unch)
WCVC : 0.0003 (+50.00%)
KALY : 0.0011 (-8.33%)
GNBT : 0.2300 (+6.98%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar